4.0
Feb 1, 2018
Recommend
CEO approval
Business Outlook
Pros
Smart, engaged people and very active fund. See most of the large deals in European healthcare. Leadership is outstanding. Ability to interact with research arm offers significant advantages for specialized topics.
Cons
The corporation Merck KGaA is probably one of the least innovation-oriented large pharma companies out there. I was verbally abused by an administrative assistant in the office.